SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indoco Remedies gets USFDA's nod for sterile manufacturing facility

29 Mar 2019 Evaluate

Indoco Remedies has received clearance from US Food and Drug Administration (USFDA) for its sterile manufacturing facility for Finished Dosages, located at Verna Industrial Area, Goa (Plant II). USFDA has signified that the site has come out of the ‘Warning Letter’ issued to the site in March 2017.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.

Indoco Remedies Share Price

234.05 -3.15 (-1.33%)
25-Jun-2026 12:01 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1878.50
Dr. Reddys Labs. 1353.20
Cipla 1441.80
Zydus Lifesciences 1100.20
Lupin 2370.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: